Moran, A., Ramakrishnan, S., Borg, C., Connolly, C., Couillard, S., Mwasuku, C., . . . Lehtimaki, L. (2020). Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma. European Respiratory Society.
Chicago-čujuhus (17. p.)Moran, A., S. Ramakrishnan, C. Borg, C. Connolly, S. Couillard, C. Mwasuku, I. Pavord, T. Hinks, juo L. Lehtimaki. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
MLA-čujuhus (9. p.)Moran, A., et al. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.